The Global Disposable Insulin-Delivery Device Industry has showcased remarkable resilience, achieving a commendable valuation of US$14,585.6 million in 2022. The upward trajectory is set to continue, with market experts forecasting an impressive surge to US$15,780.6 million by 2023. Buoyed by this impressive momentum, the industry is on the cusp of a transformative journey, with a …